Material Type
Poster
Cost-Effectiveness of Axicabtagene Ciloleucel Vs. Tisagenlecleucel for the Treatment of 3L+ Relapsed/Refractory Large B-Cell Lymphoma in the United States: Incorporating Longer Survival Results
Author: Oluwole, O
Yescarta
Poster
Axicabtagene Ciloleucel Vein-to-vein Time in Trial or Real-world Settings vs Other CAR T-cell Therapies for Relapsed/Refractory Large B-cell Lymphoma: a Systematic Literature Review and Meta-analysis
Author: Locke, F
Yescarta